|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-2-28
|
|
pubmed:abstractText |
To compare the cost-effectiveness of eflornithine and melarsoprol in the treatment of human African trypanosomiasis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1365-3156
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
265-71
|
|
pubmed:meshHeading |
pubmed-meshheading:18304274-Angola,
pubmed-meshheading:18304274-Animals,
pubmed-meshheading:18304274-Cost of Illness,
pubmed-meshheading:18304274-Cost-Benefit Analysis,
pubmed-meshheading:18304274-Eflornithine,
pubmed-meshheading:18304274-Humans,
pubmed-meshheading:18304274-Melarsoprol,
pubmed-meshheading:18304274-Treatment Outcome,
pubmed-meshheading:18304274-Trypanocidal Agents,
pubmed-meshheading:18304274-Trypanosomiasis, African
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
|
|
pubmed:affiliation |
Institute of Tropical Medicine, Antwerp, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
